214 related articles for article (PubMed ID: 35778768)
1. Clinical and laboratory evaluation of sicca complaints: distinctive aspects of primary, secondary and non-Sjogren syndrome.
de Oliveira FR; Motta ACF; Módulo CM; Garcia DM; Chiorini JA; Louzada-Junior P; Rocha EM
Adv Rheumatol; 2022 Jul; 62(1):23. PubMed ID: 35778768
[TBL] [Abstract][Full Text] [Related]
2. Overlap of ACA-positive systemic sclerosis and Sjögren's syndrome: a distinct clinical entity with mild organ involvement but at high risk of lymphoma.
Baldini C; Mosca M; Della Rossa A; Pepe P; Notarstefano C; Ferro F; Luciano N; Talarico R; Tani C; Tavoni AG; Bombardieri S
Clin Exp Rheumatol; 2013; 31(2):272-80. PubMed ID: 23343785
[TBL] [Abstract][Full Text] [Related]
3. sICAM-1 as potential additional parameter in the discrimination of the Sjögren syndrome and non-autoimmune sicca syndrome: a pilot study.
Zinkevičienė A; Dumalakienė I; Mieliauskaitė D; Vilienė R; Narkevičiūtė I; Girkontaitė I
Clin Rheumatol; 2019 Oct; 38(10):2803-2809. PubMed ID: 31152257
[TBL] [Abstract][Full Text] [Related]
4. Proteomic and histopathological characterisation of sicca subjects and primary Sjögren's syndrome patients reveals promising tear, saliva and extracellular vesicle disease biomarkers.
Aqrawi LA; Galtung HK; Guerreiro EM; Øvstebø R; Thiede B; Utheim TP; Chen X; Utheim ØA; Palm Ø; Skarstein K; Jensen JL
Arthritis Res Ther; 2019 Jul; 21(1):181. PubMed ID: 31366407
[TBL] [Abstract][Full Text] [Related]
5. Comparative analysis of the 2016 ACR-EULAR and the 2002 AECG classification criteria for Sjögren's syndrome: Findings from the NIH cohort.
Billings M; Amin Hadavand M; Alevizos I
Oral Dis; 2018 Mar; 24(1-2):184-190. PubMed ID: 29480635
[TBL] [Abstract][Full Text] [Related]
6. Proteomic analysis of saliva: a unique tool to distinguish primary Sjögren's syndrome from secondary Sjögren's syndrome and other sicca syndromes.
Baldini C; Giusti L; Ciregia F; Da Valle Y; Giacomelli C; Donadio E; Sernissi F; Bazzichi L; Giannaccini G; Bombardieri S; Lucacchini A
Arthritis Res Ther; 2011; 13(6):R194. PubMed ID: 22117835
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Effect on Sicca Symptoms of Anticentromere Antibody-positive Sjögren Syndrome and Primary Sjögren Syndrome Alone.
Li Y; Bookman AAM
J Rheumatol; 2020 Jun; 47(6):876-880. PubMed ID: 31615914
[TBL] [Abstract][Full Text] [Related]
8. [Sjögren's Syndrome: Epidemiological, Diagnostic, Therapeutic and Evolutionary Aspects in the Aristide-Le-Dantec Teaching Hospital of Dakar, Senegal (2012-2016)].
Salissou GM; Moustapha N; Kaba C; Coumba D; Saïdou D
Bull Soc Pathol Exot; 2020; 113(3):136-142. PubMed ID: 33825393
[TBL] [Abstract][Full Text] [Related]
9. Salivary cytokine profiles in primary Sjögren's syndrome differ from those in non-Sjögren sicca in terms of TNF-α levels and Th-1/Th-2 ratios.
Kang EH; Lee YJ; Hyon JY; Yun PY; Song YW
Clin Exp Rheumatol; 2011; 29(6):970-6. PubMed ID: 22132900
[TBL] [Abstract][Full Text] [Related]
10. Secondary Sjogren's Syndrome in 83 Patients With Rheumatoid Arthritis.
Hajiabbasi A; Shenavar Masooleh I; Alizadeh Y; Banikarimi AS; Ghavidel Parsa P
Acta Med Iran; 2016 Jul; 54(7):448-53. PubMed ID: 27424016
[TBL] [Abstract][Full Text] [Related]
11. Clinical and laboratory findings of primary Sjögren's syndrome patients without sicca symptoms.
Chatzis LG; Koulouri V; Baldini C; Pezoulas VC; Voulgari PV; Skopouli FN; Fotiadis DI; Tzioufas AG; Goules AV
Clin Exp Rheumatol; 2022 Dec; 40(12):2298-2302. PubMed ID: 36200933
[TBL] [Abstract][Full Text] [Related]
12. Clinical usefulness of anti-muscarinic type 3 receptor autoantibodies in patients with primary Sjögren's syndrome.
Mona M; Mondello S; Hyon JY; Saleh W; Han K; Lee HJ; Ha YJ; Kang EH; Lee YJ; Cha S
Clin Exp Rheumatol; 2021; 39(4):795-803. PubMed ID: 33124573
[TBL] [Abstract][Full Text] [Related]
13. [Epidemiology of primary Sjörgren's syndrome].
Westhoff G; Zink A
Z Rheumatol; 2010 Feb; 69(1):41-9. PubMed ID: 20012976
[TBL] [Abstract][Full Text] [Related]
14. Clinical profiles of SS-ILD compared with SS-NILD in a Chinese population: a retrospective analysis of 735 patients.
Guo T; Long Y; Shen Q; Guo W; Duan W; Ouyang X; Peng H
Ann Med; 2021 Dec; 53(1):1340-1348. PubMed ID: 34402690
[TBL] [Abstract][Full Text] [Related]
15. Sjögren's syndrome and systemic lupus erythematosus: links and risks.
Pasoto SG; Adriano de Oliveira Martins V; Bonfa E
Open Access Rheumatol; 2019; 11():33-45. PubMed ID: 30774485
[TBL] [Abstract][Full Text] [Related]
16. The EULAR Sjogren's syndrome patient reported index as an independent determinant of health-related quality of life in primary Sjogren's syndrome patients: in comparison with non-Sjogren's sicca patients.
Cho HJ; Yoo JJ; Yun CY; Kang EH; Lee HJ; Hyon JY; Song YW; Lee YJ
Rheumatology (Oxford); 2013 Dec; 52(12):2208-17. PubMed ID: 24023247
[TBL] [Abstract][Full Text] [Related]
17. Histopathological differences between primary Sjögren's syndrome and Sjögren's syndrome accompanied by scleroderma.
Kucuk U; Sarioglu S; Cetin P; Sari I; Birlik M
Indian J Pathol Microbiol; 2018; 61(3):319-322. PubMed ID: 30004047
[TBL] [Abstract][Full Text] [Related]
18. Outcome measures for primary Sjögren's syndrome: a comprehensive review.
Seror R; Theander E; Bootsma H; Bowman SJ; Tzioufas A; Gottenberg JE; Ramos-Casals M; Dörner T; Ravaud P; Mariette X; Vitali C
J Autoimmun; 2014 Jun; 51():51-6. PubMed ID: 24411404
[TBL] [Abstract][Full Text] [Related]
19. Similarities and differences between primary and secondary Sjögren's syndrome.
Hernández-Molina G; Avila-Casado C; Cárdenas-Velázquez F; Hernández-Hernández C; Calderillo ML; Marroquín V; Soto-Abraham V; Recillas-Gispert C; Sánchez-Guerrero J
J Rheumatol; 2010 Apr; 37(4):800-8. PubMed ID: 20194453
[TBL] [Abstract][Full Text] [Related]
20. Sjögren's syndrome in older patients: aetiology, diagnosis and management.
Moerman RV; Bootsma H; Kroese FG; Vissink A
Drugs Aging; 2013 Mar; 30(3):137-53. PubMed ID: 23341116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
